Real-world outcomes of patients with advanced non-small cell lung cancer (aNSCLC) and autoimmune disease (AD) receiving immune checkpoint inhibitors (ICIs)

2019

Khozin S, Walker MS, Jun M, Chen L, Stepanski E, Rubinstein WS, Komatsoulis GA, Roberts J, Zhi J, Miller RS, Fukushima R, Lau D, Hyde B